Document is current

Any future updates will be listed below

367 CRISPR/Cas9 gene-edited, allogeneic anti-CD83 CAR-T cells demonstrate potent activity in GvHD and AML tumor models

Crossref DOI link: https://doi.org/10.1136/jitc-2022-SITC2022.0367

Published Online: 2022-11-07

Published Print: 2022-11

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark